Xiwen Qin

1.8k total citations
43 papers, 1.1k citations indexed

About

Xiwen Qin is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Family Practice. According to data from OpenAlex, Xiwen Qin has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 12 papers in Cardiology and Cardiovascular Medicine and 7 papers in Family Practice. Recurrent topics in Xiwen Qin's work include Blood Pressure and Hypertension Studies (7 papers), Pharmaceutical Practices and Patient Outcomes (7 papers) and Medication Adherence and Compliance (7 papers). Xiwen Qin is often cited by papers focused on Blood Pressure and Hypertension Studies (7 papers), Pharmaceutical Practices and Patient Outcomes (7 papers) and Medication Adherence and Compliance (7 papers). Xiwen Qin collaborates with scholars based in China, Australia and Hong Kong. Xiwen Qin's co-authors include Zusen Fan, Yong Tian, Xiaoxiao Zhu, Buqing Ye, Pingping Zhu, Liuliu Yang, Ying Du, Benyu Liu, Jiayi Wu and Yali Liu and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Immunity.

In The Last Decade

Xiwen Qin

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiwen Qin China 15 455 256 177 172 161 43 1.1k
José L. Gómez United States 25 471 1.0× 164 0.6× 77 0.4× 174 1.0× 199 1.2× 71 2.0k
Mary K. Samplaski United States 23 630 1.4× 97 0.4× 92 0.5× 240 1.4× 102 0.6× 70 1.8k
Monica McGrath United States 17 416 0.9× 119 0.5× 41 0.2× 178 1.0× 41 0.3× 42 1.4k
Mart Kals Estonia 23 482 1.1× 71 0.3× 82 0.5× 124 0.7× 99 0.6× 55 1.2k
David W. Bernard United States 19 451 1.0× 184 0.7× 146 0.8× 210 1.2× 53 0.3× 45 1.3k
Bei Liu China 19 290 0.6× 64 0.3× 37 0.2× 111 0.6× 99 0.6× 103 1.0k
Kazuyoshi Shigehara Japan 24 301 0.7× 139 0.5× 176 1.0× 495 2.9× 191 1.2× 162 1.9k
Avivit Peer Israel 16 136 0.3× 155 0.6× 56 0.3× 104 0.6× 67 0.4× 71 1.1k
Shan Luo China 21 372 0.8× 115 0.4× 34 0.2× 88 0.5× 152 0.9× 76 1.3k
Juliana Salazar Spain 23 494 1.1× 140 0.5× 83 0.5× 131 0.8× 39 0.2× 69 1.5k

Countries citing papers authored by Xiwen Qin

Since Specialization
Citations

This map shows the geographic impact of Xiwen Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiwen Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiwen Qin more than expected).

Fields of papers citing papers by Xiwen Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiwen Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiwen Qin. The network helps show where Xiwen Qin may publish in the future.

Co-authorship network of co-authors of Xiwen Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiwen Qin. A scholar is included among the top collaborators of Xiwen Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiwen Qin. Xiwen Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xia, Bin, Qiangsheng He, Fang Gao Smith, et al.. (2024). Individualized prevention of proton pump inhibitor related adverse events by risk stratification. Nature Communications. 15(1). 3591–3591. 13 indexed citations
3.
Lee, Hyesung, Yeon‐Hee Baek, Ju Hwan Kim, et al.. (2023). Trends of polypharmacy among older people in Asia, Australia and the United Kingdom: a multinational population-based study. Age and Ageing. 52(2). 14 indexed citations
4.
Zhang, Xiaoying, Yuyao Liu, Man Yang, et al.. (2023). Gender-specific association between the regular use of statins and the risk of irritable bowel syndrome: A population-based prospective cohort study. Frontiers in Pharmacology. 13. 1044542–1044542. 2 indexed citations
5.
He, Qiangsheng, Ying Zhou, Yuchen Liu, et al.. (2023). Genetic factors, adherence to healthy lifestyle behaviors, and risk of bladder cancer. BMC Cancer. 23(1). 965–965. 6 indexed citations
6.
Qin, Xiwen, Joseph Hung, Matthew Knuiman, et al.. (2023). Evidence-based medication adherence among seniors in the first year after heart failure hospitalisation and subsequent long-term outcomes: a restricted cubic spline analysis of adherence-outcome relationships. European Journal of Clinical Pharmacology. 79(4). 553–567. 7 indexed citations
7.
Leung, Miriam T Y, Eric Yuk Fai Wan, Xue Li, et al.. (2023). Risk of Adverse Events and Delirium after COVID-19 Vaccination in Patients Living with Dementia. Journal of the American Medical Directors Association. 24(6). 892–900.e12. 6 indexed citations
8.
He, Qiangsheng, Xiwen Qin, Yuanyuan Yu, et al.. (2023). Confounded association between proton pump inhibitor use and risk of biliary tract cancer: Result from three cohorts. International Journal of Cancer. 153(5). 942–949. 1 indexed citations
9.
Lin, Jialing, et al.. (2023). Association between proton pump inhibitor use and neurological or psychiatric disorders: a systematic review protocol. JBI Evidence Synthesis. 21(11). 2239–2246. 1 indexed citations
10.
Ma, Juan, Weitao Li, Xiwen Qin, et al.. (2023). The orphan receptor Nur77 binds cytoplasmic LPS to activate the non-canonical NLRP3 inflammasome. Immunity. 56(4). 753–767.e8. 76 indexed citations
11.
Lai, Francisco Tsz Tsun, Vincent Ka Chun Yan, Xuxiao Ye, et al.. (2023). Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19–related deaths among people with multimorbidity: a cohort study. Canadian Medical Association Journal. 195(4). E143–E152. 10 indexed citations
12.
Yang, Man, Qiangsheng He, Fang Gao, et al.. (2021). Regular use of proton-pump inhibitors and risk of stroke: a population-based cohort study and meta-analysis of randomized-controlled trials. BMC Medicine. 19(1). 316–316. 15 indexed citations
13.
Xia, Bin, Man Yang, Long H. Nguyen, et al.. (2021). Regular Use of Proton Pump Inhibitor and the Risk of Inflammatory Bowel Disease: Pooled Analysis of 3 Prospective Cohorts. Gastroenterology. 161(6). 1842–1852.e10. 53 indexed citations
14.
15.
Qin, Xiwen, et al.. (2020). Lipid-lowering medication use and cancer-specific survival among endometrial or lung cancer patients: an Australian nationwide cohort study. European Journal of Clinical Pharmacology. 77(3). 399–407. 2 indexed citations
16.
17.
Zhu, Pingping, Xiaoxiao Zhu, Jiayi Wu, et al.. (2019). IL-13 secreted by ILC2s promotes the self-renewal of intestinal stem cells through circular RNA circPan3. Nature Immunology. 20(2). 183–194. 160 indexed citations
18.
Qin, Xiwen, Tiew‐Hwa Katherine Teng, Joseph Hung, Tom Briffa, & Frank Sanfilippo. (2016). Long-term use of secondary prevention medications for heart failure in Western Australia: a protocol for a population-based cohort study. BMJ Open. 6(11). e014397–e014397. 10 indexed citations
19.
Yuan, Jin-Qiu, Yali Liu, Zu‐Yao Yang, et al.. (2013). The efficacy and safety of alpha-1 blockers for benign prostatic hyperplasia: an overview of 15 systematic reviews. Current Medical Research and Opinion. 29(3). 279–287. 33 indexed citations
20.
Yuan, Jin-Qiu, Renjie Zhang, Zu‐Yao Yang, et al.. (2013). Comparative Effectiveness and Safety of Oral Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction: A Systematic Review and Network Meta-analysis. European Urology. 63(5). 902–912. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José L. Gómez Breakdown of academic impact, for papers by Mary K. Samplaski Breakdown of academic impact, for papers by Monica McGrath Breakdown of academic impact, for papers by Mart Kals Breakdown of academic impact, for papers by David W. Bernard Breakdown of academic impact, for papers by Bei Liu Breakdown of academic impact, for papers by Kazuyoshi Shigehara Breakdown of academic impact, for papers by Avivit Peer Breakdown of academic impact, for papers by Shan Luo Breakdown of academic impact, for papers by Juliana Salazar
Rankless by CCL
2026